Revenue Growth
Net revenue grew 24% to $6.3 million in Q1 2025, compared to $5 million in the prior year period.
Eversense 365 and twiist Integration
First AID integration of Eversense 365 with twiist Automated Insulin Delivery System announced, enabling real-time readings and insulin delivery adjustments.
Collaboration with SweetSpot
New collaboration with SweetSpot enables virtual CGM monitoring, enhancing patient care and improving network-wide health outcomes.
Medicare Reimbursement Update
The 2025 physician fee schedule was updated to provide payment for the full year of Eversense, with effectiveness retroactive back to January 1.
European Launch Plans
CE Mark application filed with the notified body; European launch of Eversense 365 expected in the second half of 2025.
Improved Financial Performance
Gross profit increased to $1.5 million in Q1 2025, up from $0.3 million in the prior year period, with gross margins improving to approximately 18%.